The Importance of a Multidisciplinary Group in the Treatment of Soft Tissue Sarcomas

Author： Wiklund T. Huuhtanen R. Blomqvist C. Tukiainen E. Virolainen M. Virkkunen P. Asko-Seljavaara S. Bjorkenheim J.M. Elomaa I.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.2, 1996-02, pp. : 269-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

By Nielsen Ole S. Mouridsen Henning Daugaard Soren Verweij Jaap Dombernowsky Per Van Glabbeke Martine Kirkpatrick Anne

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

Soft Tissue Sarcomas

By Womer R.B.

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2230-2234

Elsevier

Access to resources Recommend Favorite

Pazopanib: a promising new agent in the treatment of soft tissue sarcomas

By Kasper Bernd Hohenberger Peter

Future Oncology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1373-1383

Future Medicine

Access to resources Recommend Favorite

New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children

By Gupta Abha A Pappo Alberto S

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 675-685

Future Medicine

Access to resources Recommend Favorite

The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases

By Kane John M. Finley J. William Driscoll Deborah Kraybill William G. Gibbs John F.

Sarcoma, Vol. 6, Iss. 2, 2002-06 ,pp. : 69-73

Informa Healthcare

Access to resources Recommend Favorite